Her Majesty The Queen Opens New MRI Suite of GE Healthcare Scanners in UK Hospital

Her Majesty The Queen Opens New MRI Suite of GE Healthcare Scanners in UK Hospital On 5 February Her Majesty The Queen officially opened a £3 million MRI suite housing two new GE Healthcare MR scanners at The Queen Elizabeth Hospital, King's Lynn, UK. The facility is expected to help significantly improve local diagnostic facilities for patients. This was Her Majesty The Queen’s first official visit to the hospital since 2008.

The MRI scanner suite has been open to the public since May 2012. The two GE Healthcare scanners installed at the facility, the Optima MR360 1.5T and the Optima MR450w with GEM Suite will help increase capacity for scans, predicted to increase from an annual 6,600 in 2008 to 13,000 per annum within the next few years.

The Optima*MR450w with GEM Suite has been designed with patient comfort in mind. In particular, the area where the patient lies is wider than in many conventional scanners. In addition, flexible ‘Geometry Embracing Method (GEM)' coils follow the contours of the patient’s body, allowing easier patient positioning and making for a more relaxed scanning experience. This also makes it easier for radiographers to correctly position their patients leading to a higher quality diagnostic image.

The Optima*MR360 also combines clear image quality with versatile and user-friendly features, which make it possible to produce high quality images even when scanning challenging areas such as breasts, the heart and blood vessels. It is also energy efficient, using up to 34 percent less power than previous generation MR systems.

Karl Blight, General Manager of GE Healthcare UK & Ireland, who was introduced to the Queen explained: "GE Healthcare scanners are a key part of the state of the art suite at The Queen Elizabeth Hospital and we are pleased to be part of delivering diagnostic facilities for patients here."

Barbara Cummings, Director of Planning and Performance from The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust said: "We chose GE Healthcare technology for our new MRI scanner suite as we have been impressed by the quality of the images their scanners produce and the more relaxed patient experience they allow. The Optima*MR360 1.5T and Optima*MR450w will also make it possible to carry out breast and heart scans, significantly improving the diagnostic facilities for patients in this area."

The Optima*MR360 and the Optima*MR450w with GEM Suite are two products in GE Healthcare's MR portfolio focused on humanizing MR. While the MR industry typically hasn't put people first, GE Healthcare is working to change that by continuing to develop solutions for patients of differing ages, body types, and disease symptoms.

Related news articles:

About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.

Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...